Amarin Corporation plc
AMRN US0231112063
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Berg Aaron CEO |
0.64 USD |
160,000 Bought |
102,400 USD |
02/08/2024 | 02/08/2024 |
Holt Patrick CEO |
1.09 USD |
14,426 Bought |
15,724 USD |
22/01/2024 | 22/01/2024 |
Ketchum Steven B CSO |
0.79 USD |
34,131 Sold |
26,963 USD |
12/12/2023 | 12/12/2023 |